The firm plans to build on its organ and tissue modeling technology to develop more sophisticated tests, including full-body digital twins.

The companies have been collaborating on the development of Kryptos' molecular tests, and Osang led Kryptos' $10 million financing round in 2024.

Through this platform, resistance in bacterial samples can be tested within two hours compared to 24-27 hours through other ...

Traditional diagnostic methods, such as bacterial culture and PCR-based testing, can take 24–72 hours, delaying critical ...

Antimicrobial resistance (AMR) is a critical global health challenge, requiring early and accurate detection of resistance ...

The DNA nanotechnology market is booming, driven by precision medicine and AI integration. Over 1,500 research projects and 300 clinical trials highl ...

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a ...

Bioinformatic pipeline enables high-throughput primer and guide RNA design for sensitive and specific detection of pathogens in CRISPR-based diagnostics. CRISPR-based detection has long been ...

The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to ...

Dr. Krishna Maharjan studies chromosomes and cell structures. One of Nepal’s leading cytogeneticists, he broadened my ...